Brain CD73 modulates interferon signaling to regulate glioblastoma invasion
Neuro-Oncology Advances · 06.01.2025 · 7 (1)
DOI: 10.1093/noajnl/vdaf080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 24.04.2025. Verfasst von Konstantina Kyritsi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Georgia Cancer Center at Augusta University, Augusta, GA 30912, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) is an aggressive malignant brain-tumor that invades adjacent normal brain tissue. Unlike other solid tumors, GBM is infiltrated by various normal brain cells.
Methods
We analyzed tumor invasion in the murine GSC005 glioma model using both immunodeficient and immunocompetent mice, focusing on the role of host-intrinsic and therapeutic interferon signaling in regulating glioblastoma (GBM) invasion.
Results
In this study, we observed that mouse GBM tumor GSC005 grown in immunodeficient (RAG1-KO, NSG) mice exhibited a more invasive phenotype compared to those in immunocompetent C57BL/6J mice. Immunofluorescence staining revealed the presence of vimentin + and GFAP + cells at the tumor-border interface. Bulk mRNA-seq analysis showed that GSC005 tumors in NSG mice displayed an upregulated mesenchymal signature, characterized by epithelial-to-mesenchymal transition (EMT), and downregulation of type-I and type-II interferon signaling. Our data further suggests that host-intrinsic and therapeutic type-I interferon promotes, while type-II interferon inhibits, the GBM mesenchymal signature. CD73, a key regulator of the EMT process, was found to be upregulated in GSC005 tumors in NSG mice compared to C57BL/6J mice. Mechanistic studies revealed that type-I interferon increases CD73 expression in both tumor and stromal cells, such as tumor-associated astrocytes (mAS), while type-II interferon suppresses CD73 in mAS. Functional assays indicated that CD73 modulates both type-I and type-II interferon signaling-mediated GBM invasion.
Conclusion
These findings suggest that therapies inducing type-I or type-II interferon signaling in GBM may reciprocally regulate CD73-mediated mesenchymal transitions, impacting GBM invasion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Georgia Cancer Center at Augusta University, Augusta, GA 30912, USA.
- Department of Pharmaceutical & Biomedical Sciences, University of Georgia, Augusta, GA 30602, USA (E.D.).
- Department of Biochemistry and Molecular Biology, Georgia Cancer Center at Augusta University, Augusta, GA 30912, USA.
- Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
- Department of Neuroscience & Regenerative Medicine, Augusta University, Augusta, GA 30912, USA (Q.W.).
- Department of Pediatrics, Pediatric Immunotherapy Program, Georgia Cancer Center at Augusta University, Augusta, GA 30912, USA.
ORCID-Profile: Rafal Pacholczyk, Bangxing Hong
Förderung
- NINDS NIH HHS
- National Institute of Health
Zitieren
APA
Kyritsi, K., Ye, J., Douglass, E., Pacholczyk, R., Tsuboi, N., Otani, Y., Wang, Q., Munn, D. H., Kaur, B., & Hong, B. (2025). Brain CD73 modulates interferon signaling to regulate glioblastoma invasion. Neuro-Oncology Advances, 7(1). https://doi.org/10.1093/noajnl/vdaf080
Vancouver
Kyritsi K, Ye J, Douglass E, Pacholczyk R, Tsuboi N, Otani Y, et al. Brain CD73 modulates interferon signaling to regulate glioblastoma invasion. Neuro-Oncology Advances. 2025;7(1). doi:10.1093/noajnl/vdaf080
BibTeX
@article{Kyritsi2025,
author = {Kyritsi, Konstantina and Ye, Jishi and Douglass, Eugene and Pacholczyk, Rafal and Tsuboi, Nobushige and Otani, Yoshihiro and Wang, Qin and Munn, David H and Kaur, Balveen and Hong, Bangxing},
title = {Brain CD73 modulates interferon signaling to regulate glioblastoma invasion},
journal = {Neuro-Oncology Advances},
year = {2025},
volume = {7},
number = {1},
doi = {10.1093/noajnl/vdaf080}
}
EUVIMED